Irwin Naturals Inc. (CSE: IWIN) And Braxia Scientific Corp (CSE: BRAX, OTC: BRAXF) It has signed a letter of intent (LOI) to partner to launch clinical research services across Irwin’s growing network of US-based clinics, Emergence.
Under the letter of intent, Irwin will invest up to $2 million over the next 12 months to launch initial research services starting with at least five clinics in Florida.
The companies said the partnership will create a leading mental health-focused clinical research platform designed to simplify and accelerate the in-human clinical development process of new therapies, including seamless patient recruitment, through a US Food and Drug Administration (FDA) request.
Read: Braxia Scientific Sees Second Quarter Revenue Increase, With Clinical Therapy Increased 34.5%
They noted that the partnership will support many large and small pharmaceutical sponsors, innovative biotechnology companies, medical device companies, and governmental and non-governmental organizations seeking to develop new mental health therapies in the United States.
Braxia Scientific CEO Dr. Roger McIntyre said the company has a number of ongoing clinical trials and is currently receiving requests from various pharmaceutical sponsors to support international programs to develop new mental health therapies.
“We have developed a plan to reach a broader market in the United States and the world,” he said. “This exciting partnership allows us to effectively expand our expertise by leveraging Irwin’s existing infrastructure, which is spread across a number of states in the US.”
Read: Irwin Naturals Toners License Deal to Distribute THC Products in Oregon
Added Irwin CEO Clay Irwin, “We are very pleased to have reached a new milestone in the development of our clinics by establishing a strategic relationship with Dr. McIntyre and his research team.”
“It has a solid reputation for scientific expertise, and high-quality clinical research in the areas of depression and other mental health disorders, which will enable us to grow our clinical footprint in the United States.”
Braxia Scientific is a medical research and telemedicine company with clinics providing innovative ketamine therapies for people with depression and related disorders.
Irwin Naturals’ mission is to heal the world with plant medicine. The company leverages its brand as a best-in-class herbal supplement manufacturer to enter the cannabis and cannabis industries.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie
*****
Are you looking for marijuana business guides and books about cannabis? Then you should not miss our online bookstore with hundreds of books about cannabis, CBD, THC and more!
********
